We further analyzed the nuclear translocation of p65 in CRC cells treated with shATG7 and ATG7-in-1, revealing a marked occurrence of p65 translocation from the cytoplasm to the nucleus via ATG7 inhibition (Fig. 5C-E). This evidence concerns the gene ATG7 and colorectal carcinoma.